ASSESSMENT OF THE RISK OF CARDIOVASCULAR DISEASES BY THE LEVEL OF GLYCEMIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Keywords:
diabetes mellitus, coronary heart disease, myocardial infarction.Abstract
Relevance. Type 2 diabetes mellitus is relevant because it is widespread and leads to early disability and death. Along with chronic hyperglycemia, impaired fat metabolism causes irreversible changes in a number of organs and the vascular system. This leads to the early development of diseases of the cardiovascular system, which dramatically reduces the patient's quality of life. Purpose. Assessment of the risk of cardiovascular diseases by the level of glycemia in patients with type 2 diabetes. Materials and methods. Analysis of anamnestic heart rate indicators by glycemic indices in patients with type 2 diabetes mellitus. Conclusion. Glycemic control and prescribing cardioprotective sugar-lowering drugs to prevent the development of coronary heart disease. Relevance. Type 2 diabetes is relevant because it is widespread and leads to early disability and death. Along with chronic hyperglycemia, impaired fat metabolism causes irreversible changes in a number of organs and the vascular system. This leads to the early development of diseases of the cardiovascular system, which dramatically reduces the patient's quality of life. Purpose. Assessment of the risk of cardiovascular diseases by the level of glycemia in patients with type 2 diabetes. Materials and methods. Analysis of anamnestic heart rate indicators by glycemic indices in patients with type 2 diabetes mellitus. Conclusion. Glycemic control and prescribing cardioprotective sugar-lowering drugs to prevent the development of coronary heart disease.
References
Глобальный доклад по диабету. Женева: Всемирная организация здравоохранения; 2018. Лицензия: CC BY-NC-SA 3.0 IGO.
Дедов И.И., Мокрышева Н.Г., Мельниченко Г.А. и др. Клинические рекомендации // Российская ассоциация эндокринологов. - 2020. — C.43.
Дедов И.И., Шестакова М.В., Викулова О.К. и др. Сахарный диабет в Российский Федерации: динамика эпидемиологических показателей по данным федерального регистра сахарного диабета за период 2010-2022 гг. // Сахарный диабет. -2023;26(2):104-123.
Жито А.В., Юсупова А.О., Привалова Е.В., и др. Маркеры эндотелиальной дисфункции: Е-селектин, эндотелин-1 и фактор фон Виллебранда у пациентов с ишемической болезнью сердца, в том числе, в сочетании с сахарным диабетом 2 типа // Рациональная Фармакотерапия в Кардиологии.- 2019.- T. 15, № 6. – C. 892-899.
Сергиенко В.Б., Аншелес А.А., Сергиенко И.В., и др. Взаимосвязь ожирения, уровня холестерина липопротеидов низкой плотности и перфузии миокарда у пациентов с факторами риска без сердечно-сосудистых заболеваний атеросклеротического генеза // Кардиоваскулярная терапия и профилактика. - 2021. – Т. 20, № 2. - С. 41-49.
ADA. Standarts of medical care in diabetes-2019. // Diabetes Care.- 2019. - Vol. 24, № 1. - P.1-187.
Garvey W.T., Mechanick J.I., Brett E.M., et al. Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines. American association of clinical endocrinologists and American college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity // Endocr.Pract. – 2016. Vol. 22, № 3. P. 1-203.
International Diabetes Federation/ IDF Diabetes Atlas, 10th edn. Brussels, Belgium$ 2021. Avialable from:https://www.diabetesatlas.org
Ikramuddin S., Korner J., Lee W.-J. et al. Lifestyle changes and drug treatment with vs without gastric bypass by the Ru-an-I method and control of hemoglobin A1c, LDL cholesterol and systolic blood pressure for 5 years in the study "Diabetes Surgery" // JAMA. – 2018. – Vol. 319, № 3. – P. 266-278.
Neeland I.J., Ross R., Després J.P., et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement // Lancet Diabetes Endocrinol. – 2019. – Vol. 7. – P. 715-725.
Piercy K.L., Troiano R.P. Physical Activity Guidelines for Americans From the US Department of Health and Human Services // Circ. Cardiovasc. Qual. Outcomes. – 2018. – Vol. 11.
Visseren F.L.J., Mach F., Smulders Y.M. et al. 2021 Rekomendatsii ESC po profilaktike serdechno-sosudistыx zabolevaniy v klinicheskoy praktike // Rossiyskiy kardiologicheskiy jurnal. – 2022. – Vol. 27, № 7. – P. 5155.
